•
Sep 30, 2024

CareTrust REIT Q3 2024 Earnings Report

Reported operating results for the quarter ended September 30, 2024.

Key Takeaways

CareTrust REIT reported a strong third quarter with significant investments, ATM program proceeds, and debt prepayment. The company's net income was $33.4 million, and normalized FFO reached $60.9 million. They are on track to invest approximately $1.4 billion at an average yield of approximately 9.3% by the end of the year.

Investments of $440.8 million at an estimated stabilized yield of 9.1%.

17.2 million shares sold under its ATM Program for gross proceeds of $500.1 million.

Prepayment of the entirety of the $200.0 million term loan.

Net Debt to Annualized Normalized Run Rate EBITDA of 0.08x.

Total Revenue
$77.4M
Previous year: $55.9M
+38.5%
EPS
$0.38
Previous year: $0.35
+8.6%
Net Debt to EBITDA
0.08
Previous year: 2.5
-96.8%
Quarterly Dividend
$0.29
Previous year: $0.28
+3.6%
Gross Profit
$69.5M
Previous year: $47.8M
+45.3%
Cash and Equivalents
$377M
Previous year: $3.49M
+10720.7%
Free Cash Flow
$64.4M
Previous year: $42.4M
+52.0%
Total Assets
$2.92B
Previous year: $1.77B
+65.2%

CareTrust REIT

CareTrust REIT

Forward Guidance

The Company updated guidance for 2024, with Mr. Wagner projecting on a per-diluted weighted-average common share basis net income of approximately $0.83 to $0.84, normalized FFO of approximately $1.49 to $1.50, and normalized FAD of approximately $1.53 to $1.54.

Positive Outlook

  • All investments year-to-date
  • No new investments, other than the Northeast acquisition expected to close in November 2024
  • Dispositions and loan repayments made to date
  • No new dispositions or loan repayments beyond those completed or announced to date
  • Estimated 2.5% CPI-based rent escalators under CareTrust's long-term net leases

Challenges Ahead

  • Guidance is based on a diluted weighted-average common share count of 152.6 million shares
  • No new debt incurrences
  • No new equity issuances
  • The Company updated guidance for 2024
  • There can be no assurance that the Company’s expectations will be attained